| |
| |
|
| Insider
Information: |
Kirn David |
| Relationship: |
|
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,059,153 |
|
|
Indirect Shares
|
600,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,659,153 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
4d Molecular Therapeutics Inc. |
FDMT |
|
2024-02-08 |
1,059,153 |
2023-05-02 |
600,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2024-02-08 |
4 |
AS |
$27.13 |
$2,495,822 |
D/D |
(92,001) |
1,059,153 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2024-01-23 |
4 |
AS |
$18.41 |
$104,851 |
D/D |
(5,696) |
1,151,154 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2024-01-05 |
4 |
AS |
$19.56 |
$552,478 |
D/D |
(28,237) |
1,156,850 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2024-01-04 |
4 |
AS |
$20.31 |
$827,202 |
D/D |
(40,732) |
1,185,087 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-12-18 |
4 |
AS |
$18.13 |
$85,243 |
D/D |
(4,702) |
1,225,819 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-12-15 |
4 |
AS |
$17.27 |
$494,432 |
D/D |
(28,632) |
1,230,521 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-05-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
600,000 |
600,000 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-05-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
600,000 |
1,259,153 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-02-22 |
4 |
AS |
$20.22 |
$332,665 |
D/D |
(16,449) |
1,859,153 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-02-21 |
4 |
AS |
$20.93 |
$377,209 |
D/D |
(17,997) |
1,875,602 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-01-20 |
4 |
AS |
$20.19 |
$174,127 |
D/D |
(8,625) |
1,893,599 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • – |
2023-01-19 |
4 |
AS |
$20.03 |
$218,347 |
D/D |
(10,899) |
1,902,224 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • • |
2022-12-16 |
4 |
AS |
$22.66 |
$1,241,577 |
D/D |
(53,944) |
1,913,123 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Chief Executive Officer |
• • • |
2022-12-15 |
4 |
AS |
$23.56 |
$776,767 |
D/D |
(32,933) |
1,967,067 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
See RemarksOfficer |
• • • |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000,000 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
